Nicotinell Lakrits (Nicotine Polacrilex)

Nicotine polacrilex, the active ingredient in Nicotinell Lakrits, is a nicotine replacement therapy presented as a buccal delivery system for buccal use. It helps adults who smoke to manage withdrawal symptoms and cravings during cessation attempts.

GNH USA supplies Nicotinell Lakrits as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Nicotinell Lakrits is a nicotine replacement therapy that addresses nicotine dependence and supports quitting smoking. - Smoking cessation: reduces withdrawal symptoms and cravings, facilitating a smoother transition to a smoke‑free life. - Tobacco dependence: provides controlled nicotine exposure to lessen the urge to smoke. - Relapse prevention: helps maintain abstinence by delivering steady nicotine levels during high‑risk periods.

Nicotinell Lakrits may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Mouth irritation: mild soreness or tingling at the site of placement. - Nausea: occasional upset stomach or feeling of queasiness. - Headache: mild to moderate head discomfort. - Dizziness: transient light‑headedness. - Increased salivation: excess saliva production. - Indigestion: mild heartburn or dyspepsia.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Persistent throat irritation: severe or prolonged soreness. - Cardiovascular events: chest pain or palpitations (rare). - Severe nausea/vomiting: uncontrollable episodes. - Hypotension: unusually low blood pressure. - Stevens‑Johnson syndrome: rare severe skin reaction.

Before using Nicotinell Lakrits, consider the following safety measures. - Cardiovascular disease: consult a healthcare professional if you have heart conditions. - Pregnancy: discuss risks with a physician before use. - Breastfeeding: seek medical advice regarding exposure to the infant. - Pediatric use: not recommended for children under 18 years. - Concomitant nicotine products: avoid using other nicotine sources simultaneously. - Storage: Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Nicotinell Lakrits can interact with certain medications and substances.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may increase hypertensive risk. - Certain antihypertensives: nicotine can counteract blood‑pressure‑lowering effects.

Moderate Interactions (Monitor Closely): - Caffeine: nicotine may enhance stimulant effects, leading to jitteriness. - Antidepressants (SSRIs, SNRIs): monitor for increased anxiety or insomnia. - Antipsychotics: nicotine may alter plasma levels, requiring dose adjustment. - Alcohol: combined use can increase cardiovascular strain. - Herbal supplements (e.g., St. John’s wort): may affect nicotine metabolism.